March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Effect of Sedation with Xylazine-Ketamine on Intraocular Pressure in Laboratory Rabbits
Author Affiliations & Notes
  • Dana L. Holve
    Ophthalmology, Eye Care for Animals, Tustin, California
  • Stacy L. Pritt
    Absorption Systems, Inc, San Diego, California
  • Miriam M. Abiad
    Absorption Systems, Inc, San Diego, California
  • Tae S. Sung
    Absorption Systems, Inc, San Diego, California
  • Kyle D. Kuibarsh
    Absorption Systems, Inc, San Diego, California
  • Lyle R. Miller
    Absorption Systems, Inc, San Diego, California
  • Glenwood G. Gum
    Absorption Systems, Inc, San Diego, California
  • Ismael Hidalgo
    Absorption Systems, Inc, Exton, Pennsylvania
  • Harikrishna Devalapally
    Ophthalmology,
    Absorption Systems, Inc, Exton, Pennsylvania
  • Footnotes
    Commercial Relationships  Dana L. Holve, None; Stacy L. Pritt, None; Miriam M. Abiad, None; Tae S. Sung, None; Kyle D. Kuibarsh, None; Lyle R. Miller, None; Glenwood G. Gum, None; Ismael Hidalgo, None; Harikrishna Devalapally, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2490. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dana L. Holve, Stacy L. Pritt, Miriam M. Abiad, Tae S. Sung, Kyle D. Kuibarsh, Lyle R. Miller, Glenwood G. Gum, Ismael Hidalgo, Harikrishna Devalapally; Effect of Sedation with Xylazine-Ketamine on Intraocular Pressure in Laboratory Rabbits. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2490.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Determine effect of intravenous (IV) and intramuscular (IM) sedation with xylazine-ketamine on intraocular pressure (IOP) in laboratory rabbits.

Methods: : Twenty female New Zealand white rabbits assigned to groups based on route of sedation (group 1, intravenous; group 2, intramuscular) with xylazine-ketamine. IOP measurements obtained at baseline (before sedation) and after administration of anesthesia as follows: group 1 at 5, 10, 20, 25 min (xylazine 4.6 mg/kg, ketamine 15.4 mg/kg; dose 0.1 ml/kg); group 2 at 10, 20, 30, 45 min (xylazine 10 mg/kg, ketamine 50 mg/kg; dose 1 ml/kg).

Results: : One-way ANOVA, student’s t-test was used with p < 0.05 considered significant difference at 95% confidence intervals. Mean baseline IOP measurements for group 1 (20.15 mmHg) and group 2 (19.03 mmHg) were not significant (p=0.0860). Compared with baseline values, IOP measurements decreased significantly in group 1 after intravenous sedation at 10, 20 and 25 min (2.73, 4.10, 4.55 mmHg; p=0.0007, 0.0001, 0.0001), but not 5 min (1.40 mmHg, p=0.07). Group 2 had significant difference at 10, 20, 30 and 45 min (2.88, 3.30, 3.95, 4.60 mmHg; p=0.0001). The difference between IOP at 10 versus 20 min was significant in group 1 (1.38 mmHg, p=0.014), but not 20 versus 25 min (0.450 mmHg, p=0.553). Group 2, the difference between IOP at 10 versus 20, 20 versus 30 and 30 versus 45 min (0.425, 0.650, 0.650 mmHg) was not significant (p=0.492, 0.282, 0.294).

Conclusions: : Sedation using IV and IM administered xylazine-ketamine caused significant decrease in IOP in clinically normal laboratory rabbits.

Keywords: intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×